Massachusetts Financial Services CO Enanta Pharmaceuticals Inc Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$41.16 - $47.47 $634,152 - $731,370
-15,407 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$43.36 - $53.53 $984,402 - $1.22 Million
-22,703 Reduced 59.57%
15,407 $705,000
Q2 2020

Aug 11, 2020
BUY
$46.37 - $57.58 $1.77 Million - $2.19 Million
38,110 New
38,110 $1.91 Million

Others Institutions Holding ENTA

# of Institutions
107
Shares Held
21.2M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $102M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email